To access AIS Channel content, please allow all cookies. Please click here to configure your preferences.
Should We Change the Strategy in Patients with Compromised Tissue in Colorectal Surgery?
Johnson & Johnson MedTech
Share
share
2020
Chat
keyboard_arrow_down
Description
keyboard_arrow_down
Dr. Roel Hompes, Dr. Masaaki Ito, Dr. Antonio M. Lacy, Dr. Yves Panis, Dr. Nicolas Rotholtz and Dr. Patricia Sylla present the "Should We Change the Strategy in Patients with Compromised Tissue in Colorectal Surgery?" event.
Program
1. Welcome & Introduction. Dr. Antonio M. Lacy (Spain).
2. Impact of laparoscopy on patients over 80 requiring colectomy. Dr. Yves Panis (France).
3. Redo anastomosis in acute and chronic colorectal leaks. Dr. Roel Hompes (Netherlands).
4. Transanal total mesorectal excision for rectal cancer in previously irradiated patients. Dr. Pat Sylla (USA).
5. Recurrent rectal cancer. Dr. Masaaki Ito (Japan).
6. The mesentery in Crohn’s disease: friend or foe? Dr. Nicolas Rotholtz (Argentina).
7. Debate and closing remarks. All faculty moderated by Dr. Antonio M. Lacy.
Faculty:
Dr. Roel Hompes, Professor of Surgery, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Dr. Masaaki Ito, Head of Colorectal Surgery Department, National Cancer Center Hospital East, Japan.
Dr. Antonio Lacy, Chief of Gastrointestinal Surgery Department in Hospital Clinic Barcelona, Spain.
Dr. Yves Panis, Head of Colorectal Surgery, Beaujoun Hospital, Clichy, France.
Dr. Nicolas Rotholtz, Chairman of General Surgery, Hospital Alemán de Buenos Aires, Argentina.
Dr. Pat Sylla, Associate Professor of Surgery, Department of Colorectal Surgery, The Mount Sinai Hospital, New York, USA.